Insider Transactions Reported by 12 Insiders of CURIS INC

Symbol
CRIS on Nasdaq
Location
Lexington, MA

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

CURIS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William Steinkrauss Chief Financial Officer $4,183,200 29 Jan 2022
Robert Martell Head of Research & Development $4,067,000 20 Jan 2023
James E. Dentzer President & CEO, Director $1,126,800 17 Mar 2026
Lori Anne Kunkel Director $987,700 31 Jan 2022
Ahmed Hamdy MD Cmo $496,000 17 Mar 2026
Diantha Duvall Cfo $422,550 17 Mar 2026
Jonathan B. Zung Cdo $422,550 17 Mar 2026
Marc Rubin Director $45,072 17 Mar 2026
John Hohneker Director $45,072 20 May 2025
Martyn D. Greenacre Director $45,072 20 May 2025
Anne Elizabeth Borgman Director $45,072 20 May 2025
Kenneth I. Kaitin Director $45,072 20 May 2025

Recent Insider Transactions by Companies or Individuals for CURIS INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Jonathan B. Zung CRIS Series C Warrant (right to buy) Award 66,667 66,667 17 Mar 2026 Direct
Jonathan B. Zung CRIS Series B Warrant (right to buy) Award 66,667 66,667 17 Mar 2026 Direct
Jonathan B. Zung CRIS Series A Warrant (right to buy) Award 66,667 66,667 17 Mar 2026 Direct
Jonathan B. Zung CRIS Series B Convertible Preferred Stock Award 50 50 17 Mar 2026 Direct
Ahmed Hamdy MD CRIS Series C Warrant (right to buy) Award 66,667 66,667 17 Mar 2026 Direct
Ahmed Hamdy MD CRIS Series B Warrant (right to buy) Award 66,667 66,667 17 Mar 2026 Direct
Ahmed Hamdy MD CRIS Series A Warrant (right to buy) Award 66,667 66,667 17 Mar 2026 Direct
Ahmed Hamdy MD CRIS Series B Convertible Preferred Stock Award 50 50 17 Mar 2026 Direct
Diantha Duvall CRIS Series C Warrant (right to buy) Award 66,666 66,666 17 Mar 2026 Direct
Diantha Duvall CRIS Series B Warrant (right to buy) Award 66,666 66,666 17 Mar 2026 Direct
Diantha Duvall CRIS Series A Warrant (right to buy) Award 66,666 66,666 17 Mar 2026 Direct
Diantha Duvall CRIS Series B Convertible Preferred Stock Award 50 50 17 Mar 2026 Direct
James E. Dentzer CRIS Series C Warrant (right to buy) Award 133,333 133,333 17 Mar 2026 Direct
James E. Dentzer CRIS Series B Warrant (right to buy) Award 133,333 133,333 17 Mar 2026 Direct
James E. Dentzer CRIS Series A Warrant (right to buy) Award 133,333 133,333 17 Mar 2026 Direct
James E. Dentzer CRIS Series B Convertible Preferred Stock Award 100 100 17 Mar 2026 Direct
Marc Rubin CRIS Series C Warrant (right to buy) Award 26,667 26,667 17 Mar 2026 Direct
Marc Rubin CRIS Series B Warrant (right to buy) Award 26,667 26,667 17 Mar 2026 Direct
Marc Rubin CRIS Series A Warrant (right to buy) Award 26,667 26,667 17 Mar 2026 Direct
Marc Rubin CRIS Series B Convertible Preferred Stock Award 20 20 17 Mar 2026 Direct
James E. Dentzer CRIS Employee stock option (right to buy) Award 360,000 360,000 20 May 2025 Direct
John Hohneker CRIS Non Qualified Stock Option Award 14,400 14,400 20 May 2025 Direct
Martyn D. Greenacre CRIS Non Qualified Stock Option Award 14,400 14,400 20 May 2025 Direct
Marc Rubin CRIS Non Qualified Stock Option Award 14,400 14,400 20 May 2025 Direct
Diantha Duvall CRIS Employee stock option (right to buy) Award 135,000 135,000 20 May 2025 Direct
Anne Elizabeth Borgman CRIS Non Qualified Stock Option Award 14,400 14,400 20 May 2025 Direct
Jonathan B. Zung CRIS Employee stock option (right to buy) Award 135,000 135,000 20 May 2025 Direct
Kenneth I. Kaitin CRIS Non Qualified Stock Option Award 14,400 14,400 20 May 2025 Direct
Ahmed Hamdy MD CRIS Employee stock option (right to buy) Award 200,000 200,000 01 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.